| DB ID | MyCo_3516 |
| Title | Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan |
| Year | 2011 |
| PMID | 21210174 |
| Fungal Diseases involved | Invasive fungal infection |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | parapsilosis |
| Organism | Candida parapsilosis |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | A total of 121 patients who underwent measurement of plasma b-D-glucan practically between April 23rd and June 4th, 2003 at Kawasaki Medical School Hospital were investigated using stored plasma samples. When multiple plasma samples were available, the sample showing the highest value with the G-MK was evaluated. |
| Cohort No. | 121 |
| Age Group | 15–91 |
| P Value | None |
| Sensitivity | 0.75 |
| Specificity | 0.916 |
| Positive Predictive Value | 0.529 |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Analytic |
| Analysis Method | Fungitec G test MK (G-MK) |
| ELISA kits | Platelia Candida Ag (BioRad, Marnes La Coquette, France), QIAamp DNA kit (QIAGEN, Hilden, Germany) |
| Assay Data | FDA approved Fungitell assay |
| Validation Techniques used | Fungitec G test MK (G-MK) |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
